Skip to main content

Table 5 Safety measures at post treatment decision (T1) and at 3-month follow-up (T2)

From: Improving treatment decision-making in bipolar II disorder: a phase II randomised controlled trial of an online patient decision-aid

 

Post-treatment decision

(T1)

3-month follow-up

(T2)

Control

Intervention

SMD (95% CI)

Control

Intervention

SMD (95% CI)

M (SD, N)

M (SD, N)

M (SD, N)

M (SD, N)

Internal State Scale

 Perceived Conflict (/500)

185 (102.44, 56)

162.98 (115.68, 57)

0.20 (−0.17, 0.57)

166.59 (101.04, 44)

155.26 (112.92, 38)

0.11 (−0.33, 0.55)

 Well Being (/300)

95.18 (47.33, 56)

102.46 (48.23, 57)

−0.15 (− 0.52, 0.22)

119.09 (73.1, 44)

134.21 (75.5, 38)

− 0.20 (− 0.64, 0.24)

 Activation (/500)

185.36 (105.76, 56)

177.72 (140.98, 57)

0.06 (−0.31, 0.43)

161.59 (108.5, 44)

186.58 (141.01, 38)

−0.20 (− 0.64, 0.24)

 Depression (/200)

90.71 (60.45, 56)

82.81 (63.74, 57)

0.13 (−0.25, 0.50)

88.86 (63.91, 44)

69.21 (58.79, 38)

0.32 (−0.12, 0.76)

State-Trait Anxiety Inventory (20–80)

50.67 (14.45, 55)

47.08 (14.99, 57)

0.24 (−0.13, 0.62)

51.21 (15.65, 44)

45.44 (15.12, 38)

0.37 (−0.07, 0.82)

  1. SMD standardised mean difference